Biological systems approach
We model the patient across interconnected systems, processes and longitudinal evidence.
Hale-X / Luxembourg
Hale-X is a deeptech MedTech company building the infrastructure AI needs to understand the individual patient—from Luxembourg to the world.
Our thesis
Hale-X provides a reusable biological and temporal foundation for applications that need individual clinical context, traceable evidence and explicit uncertainty.
We model the patient across interconnected systems, processes and longitudinal evidence.
Provenance, confidence and the boundary between observation and inference are built into the output.
A reusable platform supports defined clinical programmes, beginning with Anali-X in intensive care research.
The team
The people turning a biology-first vision into a rigorous, clinically grounded platform.

Founder & CEO
Biologist and entrepreneur with a BSc in Life Sciences and a Master’s in Entrepreneurship & Innovation from the University of Luxembourg. Astou founded Hale-X after experiencing first-hand how fragmented medical data can hide the full patient picture. She leads the company’s vision, strategy, partnerships and financing.

Co-founder & Chief Scientific Officer
Biologist trained in laboratory science and computational biomedicine, with a Master’s from the University of Luxembourg. Vânia leads Hale-X’s scientific architecture, biological modelling and validation methodology, turning complex patient data into testable, evidence-linked representations.

Technical Lead
Software engineer and hands-on engineering leader with experience in distributed systems, cloud infrastructure and high-performance technical computing. At Hale-X, Hugo leads platform architecture and delivery, translating multimodal clinical requirements into reliable, scalable software foundations.

Scientific & Clinical Research Advisor
Regenerative biologist with more than a decade of research on cellular senescence, tissue repair and limb regeneration. A lead author of peer-reviewed work from TU Dresden and trained in clinical-trial design, Catarina advises Hale-X on study design, biological interpretation and the path from research methodology to clinical validation.
Advisors
Experienced advisors who challenge our science, strategy and decisions as Hale-X grows.
AdvisorStrategic & Scientific Advisor
Full Professor of Physiology in the University of Luxembourg’s Department of Health, Medicine and Life Sciences, Special Advisor to the Rector and coordinator of UNIVERSEH. Over more than two decades at the University, Eric has held senior leadership roles spanning research, administration, technology transfer and fundraising, including nearly five years as Vice-President for Academic Affairs. He advises Hale-X on scientific strategy, institutional development and partnerships.
AdvisorLeadership & Organisational Strategy Advisor
Executive coach, Gestalt therapist, MBA, MSc and mechanical engineer. Serge has spent two decades guiding executives and steering committees through cultural and organisational transformation, after an earlier career in research, engineering and strategic project management. He advises Hale-X’s founders on leadership, governance, decision-making and the operating maturity needed to scale.
Partner & AdvisorClinical Partner & Advisor — Preventive & Longevity Medicine
Physician and preventive-medicine specialist with more than two decades in longevity and functional care. Dr. Gloria holds an MSc in Preventive Medicine from Dresden International University and has pursued advanced training in functional and clinical endocrinology. He partners with Hale-X on longitudinal patient context, biomarker interpretation and how patient-level models can remain clinically useful, human and actionable.
Work with us